Furthermore, it was also found that the combination of doxorubicin (DOX) and magnoflorine (Mag) inhibited the proliferation and migration of breast cancer, acting by suppressing autophagy induced by mTOR-dependent signaling pathway [57]. Here, MTOR is linked to breast carcinoma.